tiprankstipranks
Greenwich Lifesciences, Inc. (GLSI)
NASDAQ:GLSI
US Market
GLSI
Greenwich LifeSciences
RESEARCH TOOLSreports

Greenwich LifeSciences (GLSI) Financial Statements

444 Followers

Greenwich LifeSciences Financial Overview

Greenwich LifeSciences's market cap is currently $343.18M. The company's EPS TTM is $-1.57; its P/E ratio is -15.65; Greenwich LifeSciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.78K$ -3.61K$ -3.61K$ -3.61K$ -3.61K
Operating Income$ -19.45M$ -17.64M$ -9.33M$ -8.04M$ -4.60M
EBITDA$ -19.36M$ -17.41M$ -8.89M$ -7.82M$ -4.57M
Net Income$ -19.36M$ -17.41M$ -8.89M$ -7.83M$ -4.57M
Balance Sheet
Cash & Short-Term Investments$ -6.74M$ 4.09M$ 6.99M$ 13.47M$ 27.20M
Total Assets$ -6.74M$ 4.09M$ 6.99M$ 13.48M$ 27.22M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 6.74M$ -4.09M$ -6.99M$ -13.47M$ -27.20M
Total Liabilities$ 2.02M$ 1.56M$ 294.41K$ 262.90K$ 385.17K
Stockholders' Equity$ 1.79M$ 2.53M$ 6.70M$ 13.21M$ 26.83M
Cash Flow
Free Cash Flow$ -9.91M$ -7.27M$ -6.48M$ -6.20M$ -4.29M
Operating Cash Flow$ -9.91M$ -7.27M$ -6.48M$ -6.20M$ -4.29M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 12.00M$ 4.37M$ 0.00$ -7.54M$ 2.84M
Currency in USD

Greenwich LifeSciences Earnings and Revenue History

Income Statement >

Greenwich LifeSciences Debt to Assets

Balance Sheet >

Greenwich LifeSciences Cash Flow

Cash Flow >

Greenwich LifeSciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >